H1Bh1bdatabase.info

Employer profile

Renal Associates OF Montgomery

3 certified H-1B filings across 1 fiscal year.

FY2023 filings
3
FY2023 median
$250k
Top role
Nephrologist
3 filings
Top state
AL
3 filings

Renal Associates OF Montgomery has filed 3 certified H-1B Labor Condition Applications over FY2023. In FY2023, its median certified base salary was $250k ($250k–$250k interquartile range). The most-filed role is Nephrologist (3 filings).

Year-over-year

How Renal Associates OF Montgomery hired across H-1B fiscal years. YoY column compares to the prior FY.

FYFilingsMedian $YoY %
FY20233$250k

Top job titles

Most-filed positions, across all years (raw DOL titles).

Job TitleFilingsMedian
Nephrologist3$250k

Top worksite states

Where this employer files.

StateFilingsMedian
AL3$250k

Prevailing wage level distribution

DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.

Lvl ?
3100%

Frequently asked questions

Does Renal Associates OF Montgomery sponsor H-1B visas?
Yes. Renal Associates OF Montgomery has filed 3 certified H-1B Labor Condition Applications (LCAs) over FY2023. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
What is the median H-1B salary at Renal Associates OF Montgomery?
In FY2023, the median certified H-1B base salary at Renal Associates OF Montgomery was $250k, with a 25th–75th percentile range of $250k–$250k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
What jobs does Renal Associates OF Montgomery hire H-1B workers for?
Renal Associates OF Montgomery's most-filed H-1B role is Nephrologist (3 filings). Its top worksite state is AL.
How many H-1B filings did Renal Associates OF Montgomery submit in FY2023?
Renal Associates OF Montgomery had 3 certified H-1B LCA filings in FY2023.
Browse all 3 filings →Just FY2023